Italia markets close in 3 hours 57 minutes

SWTX Dec 2024 45.000 put

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
8,300,00 (0,00%)
In data: 11:14AM EDT. Mercato aperto.
Schermo intero
Chiusura precedente8,30
Aperto8,30
Denaro6,90
Domanda10,80
Prezzo d'esercizio45,00
Scadenza2024-12-20
Min-Max giorno8,30 - 8,30
Contratto - Min-MaxN/D
Volume26
Open Interest1,28k
  • GlobeNewswire

    SpringWorks Therapeutics Reports Second Quarter 2023 Financial Results and Recent Business Highlights

    – Presented additional Phase 3 DeFi data at ASCO demonstrating clinically significant reductions in pain and substantial reductions in tumor volume and T2 hyperintensity with nirogacestat treatment – – Completed enrollment of Phase 2 trial evaluating nirogacestat in patients with ovarian granulosa cell tumors – – Highlighted encouraging Phase 1 and 2 clinical data from emerging pipeline programs at AACR and EHA – STAMFORD, Conn., Aug. 02, 2023 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (